Search research articles
Contact Us
Filters
Showing results (171-180 of 310) with videos related to
Page
of 31
Sort By:
Plos One
|
September 11, 2010
Is IP-10 an accurate marker for detecting M. tuberculosis-specific response in HIV-infected persons?
Delia Goletti, Alamelu Raja, Basirudeen Syed Ahamed Kabeer, et al.
Frontiers in Immunology
|
November 12, 2024
Immunomodulatory effects of cysteamine and its potential use as a host-directed therapy for tuberculosis
Saeid Najafi-Fard, Chiara Farroni, Linda Petrone, et al.
International Journal of Environmental Research and Public Health
|
September 9, 2022
Latent Tuberculosis Infection in Haematopoietic Stem Cell Transplant Recipients: A Retrospective Italian Cohort Study in Tor Vergata University Hospital, Rome
Mirko Compagno, Assunta Navarra, Laura Campogiani, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
March 13, 2021
Coinfection of tuberculosis and COVID-19 limits the ability to in vitro respond to SARS-CoV-2
Linda Petrone, Elisa Petruccioli, Valentina Vanini, et al.
International Journal of Molecular Sciences
|
January 21, 2023
Cysteamine/Cystamine Exert Anti-<i>Mycobacterium abscessus</i> Activity Alone or in Combination with Amikacin
Ivana Palucci, Alessandro Salustri, Flavio De Maio, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
February 28, 2024
Perspectives on development and advancement of new tuberculosis vaccines
Christopher da Costa, Christine S Benn, Thomas Nyirenda, et al.
Cells
|
January 11, 2022
Cysteamine with In Vitro Antiviral Activity and Immunomodulatory Effects Has the Potential to Be a Repurposing Drug Candidate for COVID-19 Therapy
Tonino Alonzi, Alessandra Aiello, Linda Petrone, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
March 8, 2024
Detection of Mycobacterium tuberculosis DNA in CD34<sup>+</sup> peripheral blood mononuclear cells of adults with tuberculosis infection and disease
Federica Repele, Tonino Alonzi, Assunta Navarra, et al.
Neurology International
|
August 27, 2025
Characterization of QuantiFERON-TB-Plus Results in Patients with Tuberculosis Infection and Multiple Sclerosis
Elisa Petruccioli, Luca Prosperini, Serena Ruggieri, et al.
The Journal of Infection
|
March 4, 2014
High urine IP-10 levels associate with chronic HCV infection
Linda Petrone, Teresa Chiacchio, Valentina Vanini, et al.
Page
of 31
Search research articles
Search
Showing results (171-180 of 310) with videos related to
Sort By:
Page
of 31
Plos One
|
September 11, 2010
Is IP-10 an accurate marker for detecting M. tuberculosis-specific response in HIV-infected persons?
Delia Goletti, Alamelu Raja, Basirudeen Syed Ahamed Kabeer, et al.
Frontiers in Immunology
|
November 12, 2024
Immunomodulatory effects of cysteamine and its potential use as a host-directed therapy for tuberculosis
Saeid Najafi-Fard, Chiara Farroni, Linda Petrone, et al.
International Journal of Environmental Research and Public Health
|
September 9, 2022
Latent Tuberculosis Infection in Haematopoietic Stem Cell Transplant Recipients: A Retrospective Italian Cohort Study in Tor Vergata University Hospital, Rome
Mirko Compagno, Assunta Navarra, Laura Campogiani, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
March 13, 2021
Coinfection of tuberculosis and COVID-19 limits the ability to in vitro respond to SARS-CoV-2
Linda Petrone, Elisa Petruccioli, Valentina Vanini, et al.
International Journal of Molecular Sciences
|
January 21, 2023
Cysteamine/Cystamine Exert Anti-<i>Mycobacterium abscessus</i> Activity Alone or in Combination with Amikacin
Ivana Palucci, Alessandro Salustri, Flavio De Maio, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
February 28, 2024
Perspectives on development and advancement of new tuberculosis vaccines
Christopher da Costa, Christine S Benn, Thomas Nyirenda, et al.
Cells
|
January 11, 2022
Cysteamine with In Vitro Antiviral Activity and Immunomodulatory Effects Has the Potential to Be a Repurposing Drug Candidate for COVID-19 Therapy
Tonino Alonzi, Alessandra Aiello, Linda Petrone, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
March 8, 2024
Detection of Mycobacterium tuberculosis DNA in CD34<sup>+</sup> peripheral blood mononuclear cells of adults with tuberculosis infection and disease
Federica Repele, Tonino Alonzi, Assunta Navarra, et al.
Neurology International
|
August 27, 2025
Characterization of QuantiFERON-TB-Plus Results in Patients with Tuberculosis Infection and Multiple Sclerosis
Elisa Petruccioli, Luca Prosperini, Serena Ruggieri, et al.
The Journal of Infection
|
March 4, 2014
High urine IP-10 levels associate with chronic HCV infection
Linda Petrone, Teresa Chiacchio, Valentina Vanini, et al.
Page
of 31